LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.48 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.44 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -4%. A quarter ago, it was expected that this medical device maker would post earnings of $0.49 per share when it actually produced earnings of $0.49, delivering no surprise.Over the last four quarters, the compa ...

LeMaitre Vascular (LMAT) Q1 2025 Earnings Call May 01, 2025 05:00 PM ET Speaker0 Welcome to the Lomate Vascular First Quarter twenty twenty five Financial Results Conference Call. As a reminder, today's call is being recorded. At this time, I would like to turn the call over to Mr. Dorian LeBlanc, Chief Financial Officer of Lemaitre Vascular. Please go ahead, sir. Speaker1 Thank you, operator. Good afternoon, and thank you for joining us on our Q1 twenty twenty five conference call. With me on today's call ...

Exhibit 99.1 LeMaitre Q1 2025 Financial Results BURLINGTON, MA, May 1, 2025 - LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q1 2025: Grafts (+17%) and carotid shunts (+14%) drove sales growth. EMEA sales increased 18%, Americas 11%, and APAC 3%. Gross margin was 69.2% (vs. 68.6% in Q1 2024), due to higher average selling prices and manufacturing efficiencies ...

BURLINGTON, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2025 results, announced a quarterly dividend of $0.20/share, and provided guidance. Q1 2025: Sales $59.9mm, +12% (+13% organic)Gross margin 69.2%, +60 bpsOp. income $12.6mm, +6%Op. margin 21%Earnings per diluted share $0.48, +10%Cash up $2.8mm sequentially to $302.5mm Grafts (+17%) and carotid shunts (+14%) drove sales growth. EMEA sales increa ...

LeMaitre Vascular (LMAT) shares soared 7.7% in the last trading session to close at $83.90. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 5.4% loss over the past four weeks.The upside can be attributed to relief-rally across global markets following the announcement of a 90-day pause on tariff hike by the United States.This medical device maker is expected to post quarterly earnings of $0.50 per share in its upcoming report, wh ...

Company Overview - LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease, which affects over 200 million people globally [3] - The company develops, manufactures, and markets both disposable and implantable vascular devices aimed at vascular surgeons [3] Financial Results Announcement - LeMaitre Vascular will release its first quarter 2025 financial results on May 1, 2025, after market close [1] - A conference call is scheduled for 5:00 PM EDT on the same day to discuss the financial results, business highlights, and company outlook [1] Access to Conference Call - Access to the live conference call requires online registration, after which registrants will receive dial-in information and a PIN [2] - The audio webcast will be available live and for replay on the company's investor relations website [2]

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8, 2025, at 3:45 PM EDT. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devic ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth stock is not easy at all.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Sty ...

Core Insights - Precision Optics Corporation has appointed Joseph P. "JJ" Pellegrino, Jr. to its Board of Directors, who will also serve as Chairman of the Audit Committee, bringing extensive operational and financial experience in the medical device industry [1][2][3] Group 1: Appointment Details - Mr. Pellegrino previously served as Chief Financial Officer of LeMaitre Vascular, Inc. from 2007 until March 2025 and has a strong background in the medical device sector [2] - He has held various positions including Executive Vice President of Finance at LeMaitre Vascular and has experience as an investment banking analyst at Lehman Brothers [2] - His educational background includes an A.B. in Economics from Harvard College and an M.B.A. from Harvard Business School [2] Group 2: Board Changes - The appointment of Mr. Pellegrino follows the retirement of Peter Anania from the Board, who contributed significantly post the acquisition of Lighthouse Imaging [3][4] - Mr. Woodward, Chairman of the Board, expressed gratitude for Mr. Anania's contributions and wished him well in future endeavors [4] Group 3: Company Overview - Precision Optics Corporation, founded in 1982, focuses on advanced optical instruments for the medical and defense/aerospace industries, leveraging proprietary technologies [5] - The company provides services from product concept to mass manufacturing, addressing the needs of the surgical community for enhanced imaging systems [5] - Precision Optics has a history of supplying a variety of optical products to top-tier medical device companies and is also involved in defense/aerospace applications [5]

BURLINGTON, Mass., March 03, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in three upcoming investor conferences in March. 37th Annual ROTH ConferenceMonday, March 17, 2025The Laguna Cliffs Marriott, Dana Point, CAManagement will present at 4:00 PM PDT KeyBanc Healthcare ForumWednesday, March 19, 2025Virtual EventManagement will present at 1:30 PM EDT Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceThursday, March 20, 20 ...